Northern Trust Corp Ab Cellera Biologics Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 81,621 shares of ABCL stock, worth $205,684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,621
Previous 39,447
106.91%
Holding current value
$205,684
Previous $102,000
134.31%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ABCL
# of Institutions
165Shares Held
120MCall Options Held
233KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$69.4 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$30.8 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$26.8 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$20 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$18.5 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $719M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...